Skip to main content
Tech.euFundingExplorerBeta

BioLamina

Stockholm-based BioTech scale-up specialising in matrix biology and cell culture,

Total raised
€20M
€20,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2026-04
latest 2026-04

Funding by year

EUR raised per year · 2026 YTD

Signals

High confidence
Raise-next likelihood19
base rate 30% for Other
  • Raised very recently
  • Low backer re-investment

Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds
DateStageAmountInvestors
2026-04-17Other€20MEuropean Investment Bank (EIB)View deal →

Related news

Similar companies

same sector or country